Efficacy of the combined therapy with etanercept and methotrexat at the female patient with generalized pustular psoriasis and arthritis psoriasis after the therapeutic failure of two the TNF-α receptor inhibitors. Case study

The article presents the clinical observation effectiveness of TNF-a inhibitor etanercept in patients with generalized pustular psoriasis and PsA, resistant to treatment by other drugs of this class. It presents the current recommendations for the management of patients with pustular psoriasis.

• Publication year

  2016

• Venue

  Vestnik Dermatologii i Venerologii

• Publication date

  2016-12-24

• Fields of study

  Not labeled

• Identifiers
  DOI 10.25208/0042-4609-2016-92-6-94-100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update

  2015cited by this paper
• Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis

  2015cited by this paper
• Psoriatic arthritis: update on pathophysiology, assessment and management

  2011cited by this paper
• 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis

  2011cited by this paper
• Management of psoriatic arthritis from the view of the dermatologist

  2011cited by this paper
• Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

  2011cited by this paper
• Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs

  2010cited by this paper
• Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data

  2010cited by this paper
• Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

  2010cited by this paper
• New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS)

  2009cited by this paper
• Treatment recommendations for psoriatic arthritis

  2008cited by this paper
• Immunopathogenesis of psoriasis

  2007cited by this paper
• Efficacy and tolerability of anti-TNF therapy in psoriatic arthritis patients: Results from the South Swedish Arthritis Treatment Group Register

  2007cited by this paper
• Psoriatic arthritis: epidemiology, clinical features, course, and outcome

  2005cited by this paper
• Epidemiology of psoriatic arthritis in the population of the United States.

  2005cited by this paper
• Pathogenesis of psoriatic arthritis

  2004cited by this paper
• Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.

  2004cited by this paper

• No citing papers are available for this paper.